On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

ChineseInvestors.com Inc. (CIIX) Continues Focus on Investor Education, CBD Biotech; Anticipates Profitable New Year

  • Maximizing profit by creating, leveraging products with 10-to-20x profitability margins
  • Investors encouraged to review CBD Biotech’s impressive product line, strategic plan for revenue increase.
  • Driving growth in new year with growing demand for CBD products

ChineseInvestors.com Inc. (OTCQB: CIIX) is a leading financial-information website for Chinese-speaking investors in the United States and China. CIIX CEO Warren Wang recently discussed the company’s goals and bright outlook for 2020 during a MoneyTV.net interview with Donald Baillargeon (http://cnw.fm/1bWeD).

The new year looks promising for CIIX, Wang stated. Using Chinese language character sets, the company offers investor-education products and services, real-time market commentary, analysis and educational-related services as well as advertising, public-relations-related support services and consultative services to smaller private companies.

In addition to financial services, the company has invested in the growing demand for cannabidiol (CBD)-based nutrition and health products. An IPO of CIIX’s wholly owned foreign enterprise, CBD Biotech, is anticipated early this year (http://cnw.fm/UbP0U). In his interview, Wang gave an overview of CBD Biotech’s impressive product line, and he urged investors to do likewise in order to grasp the company’s plan to achieve profitability.

CBD Biotech’s major asset is its 40,000 repeat customers, said Wang, who discussed a B2C division of the company whose purpose is to target these consumers through telemarking and social media. The goal is to see how to retain this targeted group and keep these customers coming back. In addition, a separate CBD Biotech B2B division is working to maximize revenue to wholesalers. The two divisions have the same goals: increase sales, lower costs and maximize profitability.

Regarding stock price, Wang pointed out the hard work of employees, the company’s revenue, and the quality of the product line and profit margins as he shared with investors his confidence in the future of CIIX. CBD cosmetics products have a 10-to-20x profit margin, Wang noted, as he explained that the CBD cosmetic product line will be a vital part of driving growth as the company works to lower costs and maximize profitability. The company achieved almost $5 million in revenue during calendar year 2019, Wang said, and he expressed his optimism regarding the upcoming year as well.

In an earlier interview with Baillargeon (http://cnw.fm/6iaCF), Wang emphasized the bright future of the hemp/CBD industry in China, which has four times the market potential of America. CBD Biotech is one of the first companies to enter the industry, solidifying its place as a big player in the future of cannabis in China.

Last year was a successful year for CIIX, and Wang is looking forward to continued profitability and successful in 2020 as the company works toward an even more stable future.

For more information, visit the company’s website at www.ChineseInvestors.com

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://cnw.fm/CIIX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Archives

Select A Month

Official NewsWire Relationships

Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition Cannexpo Marigold PR MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo Tether BudTender Tether BudTender Appreciation Week

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722